Shiaowen David Hsu

A Phase II Trial of Bevacizumab plus Everolimus for Patients with Refractory Metastatic Colorectal Cancer

Ivy Altomare, Johanna C. Bendell, Karen Bullock et al. · The Oncologist · 2011 · 65 citations · Full text

Medicine, Oncology, Pharmacology +13

Implementation of a Hepatic Artery Infusion Program: Initial Patient Selection and Perioperative Outcomes of Concurrent Hepatic Artery Infusion and Systemic Chemotherapy for Colorectal Liver Metastases

John M. Creasy, Kyle J. Napier, Sarah Reed et al. · Annals of Surgical Oncology · 2020 · 43 citations

Medicine, Oncology, Perioperative Medicine +17

A Phase II Study of Capecitabine, Oxaliplatin, and Bevacizumab in the Treatment of Metastatic Esophagogastric Adenocarcinomas

Hope E. Uronis, Johanna C. Bendell, Ivy Altomare et al. · The Oncologist · 2013 · 42 citations · Full text

Medicine, Oncology, Pharmacology +17

Improving Cancer Drug Discovery by Studying Cancer across the Tree of Life

Jason A. Somarelli, Amy M. Boddy, Heather L. Gardner et al. · Molecular Biology and Evolution · 2019 · 31 citations · Full text

Veterinary Medicine, Oncology, Veterinary Oncology +12

Phase I study of dasatinib in combination with capecitabine, oxaliplatin and bevacizumab followed by an expanded cohort in previously untreated metastatic colorectal cancer

John H. Strickler, Shannon J. McCall, Andrew B. Nixon et al. · Investigational New Drugs · 2013 · 27 citations

Medicine, Oncology, Pharmacology +11